Clinical Trials
30 trialsComprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
National Institutes of Health Clinical Center (CC)
OvAR-Y
Washington University School of Medicine
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Alliance for Clinical Trials in Oncology
iCaRe2
University of Nebraska
DP-04
AstraZeneca
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Washington University School of Medicine
BRICCS
Mayo Clinic
CAMPERR
Adela, Inc
PRIORITY
Institut Bergonié
Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics
Mayo Clinic
Eligibility Screening for the NIH Intramural Research Program Clinical Protocols
National Institutes of Health Clinical Center (CC)
PREFER
Labcorp Corporation of America Holdings, Inc
EVIDENT
Sheffield Teaching Hospitals NHS Foundation Trust
ROOT
Taproot Health
REGATA
N.N. Petrov National Medical Research Center of Oncology
MyBrain
Rigshospitalet, Denmark
PPB
Children's National Research Institute
Drug Sensitivity and Mutation Profiling
Florida International University
Computer Aided Diagnostic Tool on Computed Tomography Images for Diagnosis of Retroperitoneal Tumor in Children
West China Hospital
HSP70CTC
Charite University, Berlin, Germany
PIONEER
SpeciCare
E-MOSAIC Electronic Tool to Monitor Symptoms
Swiss Cancer Institute
N1
CureOne
Advanced MRI Sequences for Radiation Therapy Treatment Planning
Medical College of Wisconsin
CTC
Comprehensive Cancer Centers of Nevada
Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants
Wake Forest University Health Sciences
Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing Cancer
Children's Oncology Group
B-Receptor Signaling in Cardiomyopathy
Stanford University
iCAT for Recurrent/Refractory/HR Solid Tumors
Dana-Farber Cancer Institute
Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer
Children's Oncology Group